UJH-28227-90137
3 vaccinations
4 coded responses
34 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 201 / VA
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-20
Dose 1 — Moderna
-
2021-01-21
Registered in v-safe
- 2021-01-22
- 2021-01-23
-
2021-01-24
Survey response — days 1–6 daily, dose 1MedDRA: Cough, Dyspnoea — Feeling: GoodFree text: Cough, shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
- 2021-01-27
- 2021-02-03
- 2021-02-10
-
2021-02-17
Dose 2 — Moderna
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-23
- 2021-02-26
- 2021-03-03
- 2021-03-10
- 2021-03-19
- 2021-03-24
- 2021-03-31
- 2021-05-19
- 2021-08-18
-
2021-12-17
Dose 3 — Moderna
- 2021-12-17
-
2021-12-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-12-19
- 2021-12-20
- 2021-12-21
- 2021-12-23
- 2021-12-31
- 2022-01-16
- 2022-01-21
-
2022-01-28
Survey response — day 42, dose 3MedDRA: Headache — Feeling: GoodFree text: HeadachesMedDRA releases: 2024-11 · check-in free text available
-
2022-03-18
Survey response — 3 months, dose 3MedDRA: Headache — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Frequent headachesMedDRA releases: 2024-11 · check-in free text available
-
2022-03-18
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-23
- 2022-06-17
-
2022-12-17
Survey response — 12 months, dose 3MedDRA: Premature menopause — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Premature ovarian failureMedDRA releases: 2024-11 · check-in free text available
-
2022-12-17
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-19
- 2022-12-19
-
2022-12-22
Call successfulNot applicable - Accidental Reporting
-
2022-12-22
Call successfulNot applicable - Accidental Reporting
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-20 | Moderna | |
| 2 | 2021-02-17 | Moderna | |
| 3 | 2021-12-17 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Cough, shortness of breath
Release 11 — day 42, dose 3
Symptoms: Headaches
Release 11 — 3 months, dose 3
Symptoms: Frequent headaches
Release 12 — 12 months, dose 3
Symptoms: Premature ovarian failure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Premature menopause | · | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release